Your Health Matters

Actions

The Food and Drug Administration approves new guidelines for use of the Alzheimer's drug

Alzheimers Association
Posted
and last updated

BAKERSFIELD, Calif. (KERO) — The Food and Drug Administration approved new guidelines for a controversial Alzheimer's drug.

The new guidelines state the drug is for patients with early to mid-stage Alzheimer's. Drug maker Biogen said the update was made to clarify the status of the patients involved in studies that led to the drug's approval.

The FDA says its ability to reduce clumps of plaque in the brain is likely to slow Dementia.

Biogen is required to conduct a follow-up study.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Sunday

06/22/2025

Clear

-° / 61°

0%

Monday

06/23/2025

Clear

90° / 66°

0%

Tuesday

06/24/2025

Clear

95° / 66°

0%

Wednesday

06/25/2025

Clear

98° / 70°

0%

Thursday

06/26/2025

Clear

102° / 72°

0%

Friday

06/27/2025

Clear

102° / 72°

0%

Saturday

06/28/2025

Clear

103° / 73°

0%

Sunday

06/29/2025

Clear

103° / 73°

0%